Concepedia

José R. F. Corvalán

JR

10

Publications

1K

Citations

10

H-Index

1979

Active since

Affiliations

Eli Lilly (United States)(Current)

Institute of Animal Physiology of the Slovak Academy of Sciences

PhysioGenix (United States)

José R. F. Corvalán is an author at Eli Lilly (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1979–2002

10

Publications

10

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

Michael J. Mendez, Larry L. Green, José R. F. Corvalán et al. · Nature Genetics · 1997 · 373 citations

, , +14

Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states

Xiaodong Yang, José R. F. Corvalán, Ping Wang et al. · Journal of Leukocyte Biology · 1999 · 171 citations

Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer's Disease Brain

Sheila P. Little, Eric P. Dixon, Frank A. Norris et al. · Journal of Biological Chemistry · 1997 · 159 citations · Full text

New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity

Bennett C. Laguzza, Cynthia L. Nichols, George J. Cullinan et al. · Journal of Medicinal Chemistry · 1989 · 125 citations

, , +15

Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.

William J. LaRochelle, Michael Jeffers, José R. F. Corvalán et al. · PubMed · 2002 · 64 citations

, , +17

Rows per page

1–5 of 10